Holen Sie sich die Stockscreener-App
22.97
0.04%
0.0313
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt FMS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$22.94
Offen:
$22.99
24-Stunden-Volumen:
193.07K
Relative Volume:
0.80
Marktkapitalisierung:
$13.46B
Einnahmen:
$20.87B
Nettoeinkommen (Verlust:
$715.14M
KGV:
18.82
EPS:
1.2209
Netto-Cashflow:
$1.67B
1W Leistung:
-2.09%
1M Leistung:
-0.61%
6M Leistung:
+20.85%
1J Leistung:
+18.79%
1-Tages-Spanne:
$22.95
$23.05
1-Wochen-Bereich:
$22.86
$23.73
52-Wochen-Spanne:
$17.93
$25.25
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Firmenname
Fresenius Medical Care Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie FMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.97 | 13.46B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
HCA
Hca Healthcare Inc
|
320.29 | 79.84B | 70.60B | 5.76B | 5.64B | 21.97 |
|
THC
Tenet Healthcare Corp
|
134.24 | 13.41B | 20.97B | 3.13B | 2.39B | 31.21 |
|
DVA
Davita Inc
|
143.12 | 12.80B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
182.91 | 12.15B | 15.42B | 1.03B | 956.84M | 15.02 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Eingeleitet | Berenberg | Buy |
| 2024-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Hochstufung | Societe Generale | Hold → Buy |
| 2023-08-14 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Fortgesetzt | Citigroup | Neutral |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-03-07 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-03 | Herabstufung | Jefferies | Buy → Underperform |
| 2022-10-26 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-27 | Hochstufung | Jefferies | Underperform → Buy |
| 2022-02-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-11-23 | Eingeleitet | HSBC Securities | Hold |
| 2021-11-11 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-20 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Hochstufung | Jefferies | Hold → Buy |
| 2019-06-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Hochstufung | UBS | Neutral → Buy |
| 2018-08-28 | Hochstufung | HSBC Securities | Hold → Buy |
| 2018-07-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Hochstufung | UBS | Sell → Neutral |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-07-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2016-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Hochstufung | Goldman | Neutral → Buy |
| 2015-08-13 | Herabstufung | Societe Generale | Buy → Hold |
| 2015-07-31 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Bestätigt | Feltl & Co. | Hold |
| 2013-01-14 | Hochstufung | HSBC Securities | Neutral → Overweight |
Alle ansehen
Fresenius Medical Care Ag Adr Aktie (FMS) Neueste Nachrichten
Growing Stronger Together: Embracing Diversity - Fresenius Medical Care
Corporate Citizenship - Fresenius Medical Care
Fresenius Medical Care: A 'Buy' Going Into 2025 (NYSE:FMS) - Seeking Alpha
Virtual reality as the next step in patient empowerment - Fresenius Medical Care
Coming Back Home: Dr. Len Usvyat Appointed as the Next Head of the Renal Research Institute - Fresenius Medical Care
17,962 miles halfway around the world - Fresenius Medical Care
“How can we improve and speed up medical decisions?” - Fresenius Medical Care
20 years creating a future worth living - Fresenius Medical Care
When Maria struck — One year after the hurricane - Fresenius Medical Care
Corporate Movie 2021 - Fresenius Medical Care
The Next Level of Renal Care - Fresenius Medical Care
Me and my four kidneys - Fresenius Medical Care
A superhero wins over Asia-Pacific - Fresenius Medical Care
Joining forces for a better future - Fresenius Medical Care
Improving dialysis through knowledge sharing in Southeast Asia - Fresenius Medical Care
A truly miraculous story – 50 years on dialysis - Fresenius Medical Care
Smart Companion for an active lifestyle - Fresenius Medical Care
The future is purple - Fresenius Medical Care
Regenerative Medicine: The road to healing - Fresenius Medical Care
The Life Long Learner - Fresenius Medical Care
Africa changing times - Fresenius Medical Care
A journey of friendship: How home hemodialysis changed Annalese's life - Fresenius Medical Care
20 years Fresenius Medical Care - Fresenius Medical Care
Making transplants safer and more widely available - Fresenius Medical Care
Remuneration of the Supervisory Board - Fresenius Medical Care
Compensation of the Management Board - Fresenius Medical Care
The Impact of Antihypertensive Medications on Intradialytic Hypotension - Fresenius Medical Care
High-Volume HDF, reduced mortality & patient-reported outcomes - Fresenius Medical Care
“How can we offer our patients the best possible treatment?” - Fresenius Medical Care
Wearable Artificial Organs Global Market Research 2023-2024 & Forecasts to 2034: Government Funding and Initiatives, & Patient Preference for Non-Invasive Solutions Boost Growth - GlobeNewswire Inc.
A Savior Overlooked - Fresenius Medical Care
Global development in the new Technology Center in Schweinfurt. - Fresenius Medical Care
Diary of a dialysis patient - Fresenius Medical Care
Dialysis in a familiar environment - Fresenius Medical Care
“How do we gain greater recognition for nursing care?” - Fresenius Medical Care
Superior Care Down Under - Fresenius Medical Care
Our Commitment - Fresenius Medical Care
A vast island nation - Fresenius Medical Care
An Introduction to the Renal Research Institute - Fresenius Medical Care
You know You Were Lucky If Saying Goodbye is Hard - Fresenius Medical Care
A market in motion - Fresenius Medical Care
The Far-Reaching Impacts of the CONVINCE Study - Fresenius Medical Care
We All Can Make a Difference - Fresenius Medical Care
Saving lives – with and beyond dialysis - Fresenius Medical Care
An almost normal life thanks to home dialysis - Fresenius Medical Care
Celebrating our nurses around the world - Fresenius Medical Care
Former CEO Rice Powell's inspiring visit to South Africa - Fresenius Medical Care
Dialysis Nurse Becomes Kidney Patient After COVID-19 - Fresenius Medical Care
New era in kidney care is on the horizon - Fresenius Medical Care
Annual Press Conference 2025 - Fresenius Medical Care
From Kidney Failure to Fresenius Medical Care Employee: A Transplant Story - Fresenius Medical Care
Finanzdaten der Fresenius Medical Care Ag Adr-Aktie (FMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):